In the biological systems of multicellular animals, a continuous cycle of cellular turnover is facilitated by stem cells, ...

By refining stem cell-based embryo models, this discovery supports the design of targeted therapies, advances regenerative medicine, and improves our ability to explore the earliest stages of life.

Building on the work of Dr. Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells, Watt and his collaborators have taken this work ...

By refining stem cell-based embryo models, this discovery supports the design of targeted therapies, advances regenerative medicine, and improves our ability to explore the earliest stages of life.

Human Autologous Mesenchymal Stem Cells is under clinical development by Bioinova and currently in Phase II for Cartilage Degeneration.

Human Amniotic Epithelial Stem Cells is under clinical development by iCELL Biotechnology and currently in Phase I for Parkinson's Disease.

Building on the work of Dr. Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells, Watt and his collaborators have taken this work ...

Tumor progression was monitored at multiple stages, from early hyperplasia to ... suppresses the tumorigenic potential of lung AT2 stem cells. Aged mice exhibited reduced tumor initiation and ...

such as radiation or stem cell transplant. Read about R-CHOP chemotherapy. The continual improvement of available treatment options means doctors may sometimes be able to cure stage 4 lymphoma ...

A Memorandum of Understanding (MoU) has been signed between Hoa Lam Shangri-La Healthcare of Hoa Lam Group and Japan-based ...